| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.4 | 0.01 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.02 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.02 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.02 |